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Introduction
Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide, especially in several areas of Asia and Africa. 1 Since HCC is known to be associated with chronic liver disease with hepatitis B virus (HBV) or hepatitis C virus (HCV), the close follow-up of patients with chronic HBV or HCV infections by imaging techniques and serum ␣-fetoprotein (AFP) assays has led to the detection of HCC at early stage. 2 However, even then surgical candidates are few, because a large proportion of patients with HCC have underlying severe liver cirrhosis with a limited hepatic reserve. 3 Moreover, clinical observations have shown that tumor recurrence rates are very high in patients with HCC who received medical or surgical treatments including liver transplantation. Thus, new treatment modalities for HCC have been investigated. One approach is gene therapy using a retroviral vector carrying a kill or suicide gene such as the herpes simplex virus thymidine kinase (HSVtk) gene. [4] [5] [6] Retroviruses can stably integrate their genes into proliferating cells, but they cannot into quiescent cells. The killing effect of the HSV-tk gene product on the virus-infected cells is seen in only proliferating cells, where HSV-tk can efficiently phosphorylate nucleoside analogues and the phosphorylated products act as a chain terminator of DNA synthesis, leading to cell death. [7] [8] [9] If the HSVtk gene is driven by the tumor-specific promoter, it can cause the selective ablation of tumor cells.
We previously constructed the recombinant retrovirus carrying the HSVtk gene under the control of the wildtype of the 0.3 kb human AFP promoter (LNAFW0.3TK). 5 The high AFP-producing hepatoma cells infected by this recombinant retrovirus expressed the HSVtk gene, resulting in induction of an efficient ganciclovir (GCV)-mediated cytotoxicity in these cells. In contrast, retroviral infection had little effect on the low AFP-producing hepatoma cells, because the wild-type of the promoter was not enough to express the HSVtk gene in the low AFPproducing cells or could not sensitize these cells to GCV.
In the present study, we investigated whether the variant-type of the 0.3 kb human AFP promoter with a G-to-A substitution at nucleotide −119 which is identified in hereditary persistence of human AFP (HPAFP), 10 a nonpathogenic condition with the elevated level of serum AFP, could function in human hepatoma cells, particularly in the low AFP-producing cells. We also constructed a hybrid gene in which the HSVtk gene expression is regulated by the variant-type of the 0.3 kb human AFP promoter, and inserted it into a retroviral vector (LNAFM0.3TK). We determined the sensitivities of the virus-infected AFP-producing human hepatoma cell lines, HuH-7, PLC/PRF/5 and huH-1/cl.2, to GCV using the colorimetric method. In addition, since the bystander effect which is exerted by the gene-transduced cells to neighboring nontransduced cells is a key factor involved in cancer gene therapy using the HSVtk/GCV system, 11 the bystander effect was analyzed in the virus-infected HuH-7 cells. Comparison of bystander effect between LNAFW0.3TK and LNAFM0.3TK infections in HuH-7 cells To compare the bystander effects induced by LNAFW0.3TK and LNAFM0.3TK infections, the virusinfected HuH-7 cells and the parental cells were cocultured at different ratios in the absence or presence of 10 m GCV for 4 days. As shown in Figure 5 , the bystander effects were observed in both LNAFW0.3TK and LNAFM0.3TK infections. However, its efficacy induced by the LNAFM0.3TK infection was superior to that induced by the LNAFW0.3TK infection. In fact, when the cell population contained 5% of the virusinfected cells, the percentages of cell survival by the LNAFW0.3TK and the LNAFM0.3TK infections were 70% and 40%, respectively (P Ͻ0.01).
Results

Activities
Discussion
Gene therapy is one of the promising treatment modalities for cancer, especially HCC, because the prognosis of patients with HCC remains as yet unsatisfactory despite recent advances in medical or surgical treatments. 1, 3 We previously showed that the retroviral vector expressing the HSVtk gene under the control of the wildtype of the 0.3 kb human AFP promoter (LNAFW0.3TK) represented a selective killing effect on the virus-infected high AFP-producing human hepatoma cells, HuH-7, by GCV exposure, but it did not affect cell growth of the low AFP-producing human hepatoma cell lines such as huH-1/cl.2.
5 Therefore, the viral vector which allows a selective and more sufficient suicide gene expression would be required in the gene therapy strategy for HCC. The AFP gene is repressed during the neonatal period. However, most hepatoma cells re-express the AFP gene. 12 There has been a great deal of progress in characterization of cis-and trans-acting elements regulating the human AFP gene. [13] [14] [15] [16] [17] The AFP gene silencer elements existing between its enhancer and promoter regions play a major role in repressing the AFP gene expression in the low AFP-producing hepatoma cells. 18, 19 In addition, McVey et at 10 have recently shown that only a G-to-A substitution at nucleotide −119 in the human AFP promoter is responsible for hereditary persistence of human AFP (HPAFP). In the present study, we constructed the retroviral vector in which the variant-type of the 0.3 kb human AFP promoter with a G-to-A substitution at nucleotide −119, a point mutation relevant to HPAFP, regulates the HSVtk gene expression (LNAFM0.3TK), and evaluated its efficacy in gene therapy for HCC.
In the CAT plasmid transfection experiments, the activity of the variant-type of the human AFP promoter was much higher than that of the wild-type of the promoter in both HuH-7 and huH-1/cl.2 cells. The 0.3 kb human AFP promoter sequence contains several cis-acting elements. 20, 21 The binding sites of the two transcriptional factors, hepatocyte nuclear factor-1 (HNF-1), a liver-specific transcriptional factor regulating many liverspecific genes including AFP, and nuclear factor-1 (NF-1) overlap in the promoter region, −118 to −130 and −108 to −121, respectively. Bois-Joyeux et al 22 have recently demonstrated that transduction of NF-1 in certain human hepatoma cells reduces the activity of the AFP promoter by the competitive inhibition of the binding of HNF-1 to the overlapping cis-acting element. The G-to-A substitution at nucleotide −119 in the human AFP promoter creates a relatively lower affinity for NF-1 together with a relatively higher affinity for HNF-1, compared with the wild-type of the promoter sequence. 10 This accounts for the increased AFP promoter activity by a G-to-A substitution at nucleotide −119 in the promoter sequence as is seen in our study, which is also manifested by HPAFP.
The LNAFM0.3TK infection provided enough sensitivities to GCV, not only in HuH-7 cells but also in huH-1/cl.2 cells (ID 50 = 0.5 m and 4.5 m, respectively). The GCV-mediated cytotoxicity was not found in the virusinfected nonhepatoma cells (HeLa). In addition, since successful application of suicide gene therapy for cancer, in part, relies on the bystander effect, where the active chemotherapeutic agent produced in target cells diffuses from cells to neighboring tumor cells at concentrations enough to inhibit cell growth, the bystander effects were compared in the LNAFW0.3TK-infected and the LNAFM0.3TK-infected HuH-7 cells. The LNAFM0.3TK infection caused a more efficient growth inhibition of the parental cells in coculture with the virus-infected cells than the LNAFW0.3TK infection. These results are likely to reflect the difference in the AFP promoter activities between the wild-type and the variant-type of the sequence, which is manifested by the findings of the CAT plasmid transfection assay in the current study and suggest that the variant-type of the 0.3 kb human AFP promoter is enough to induce the tissue-specific expression of the therapeutic gene, leading to a sufficient tumoricidal effect in combination with GCV treatment particularly in the low AFP-producing human hepatoma cells.
Clinical observations show that HCCs develop in cirrhotic liver, where some hepatocytes can produce very low levels of AFP. However, by the in situ hybridization method, we previously reported that AFP mRNA expression was found exclusively in hepatoma cells, but not in the surrounding nontumorous cells in the liver tissues obtained from patients with HCC and liver cirrhosis. 23 Accordingly, AFP expression in most hepatocytes seems to be lower than that in transformed cells, where our vector provided GCV-mediated cytotoxicities parallel with the ability of AFP production. Moreover, we utilized the properties of retrovirus vector and the HSVtk/GCV system, where only proliferating cells are affected by this system. Cell proliferation activities in HCC are much higher than those in the nontumorous tissue of liver. 24 Retroviruses can stably integrate their genes into proliferating cells that actively synthesize DNA, but cannot into quiescent cells. 7 The killing effect of the HSVtk product on the virus-infected cells is seen in only proliferating cells. 8, 9 These properties may involve the selective killing effect in hepatoma cells.
In this study, we did not present an in vivo trial of this vector system. However, we previously reported an animal model, in which LNAFW0.3TK virus-infected hepatoma cells implanted subcutaneously in athymic mice were treated with GCV. 25, 26 The GCV-mediated tumor cytotoxicity in vivo correlated closely with that in vitro. Accordingly, the current in vitro results would be applicable to the in vivo model.
We and some investigators employed the 5Ј-flanking sequence of the human AFP gene as an internal promoter regulating the specific gene expression. 4, 5, 27, 28 Previous studies showed that the AFP gene regulatory elements succeeded in the selective gene delivery to the AFP-producing hepatoma cells. In the strategy of gene therapy, a shorter length of an internal promoter is favorable, because a long 5Ј-flanking sequence would contain a variety of cis-or trans-acting elements bound to known or unknown transcriptional factors, which might cause unexpected effects on the therapeutic gene expression in vivo in the virus-infected cells. The LNAFM0.3TK contains the only 0.3 kb of the human AFP promoter with a G-to-A substitution at nucleotide −119. However, it can result in an efficient induction of the GCV-mediated cytotoxicity even in the low AFP-producing human hepatoma cells. Thus, our construct seems to be a possible line of approach involved in gene therapy for HCC.
Materials and methods
Cell culture
The amphotropic retrovirus packaging cell line, PA317 and ecotropic packaging cell line, Psi-2, were cultured in DMEM with 5% FBS. The human hepatoma and nonhepatoma cell lines were cultured in IS-RPMI (HuH-7), a chemically modified RPMI formulation as described previously, 29, 30 with 10% FBS (HeLa) or 2% FBS (PLC/PRF/5 and huH-1/cl.2).
Chloramphenicol acetyltransferase (CAT) assay
The pBR-CAT plasmid contains the CAT coding sequence and the SV40 polyadenylation signal, but no upstream regulatory sequences. 16, 31 pAFW0.3-CAT contains the 0.3 kb human AFP promoter between −230 and +29 bp relative to the AFP 5Ј-flanking sequence linked to the CAT gene in pBR-CAT. pAFM0.3-CAT contains the recombinant 0.3 kb fragment that contains a G-to-A substitution at nucleotide −119 in the human AFP promoter. Transfection was performed using 10 g of plasmid DNA per dish (60 cm 2 ) by the lipofection method. 32 Two days later, the cells were harvested and lysed by five cycles of freezing and thawing. The lysate was heated at 60°C for 10 min, centrifuged at 12 000 g for 5 min and the supernatant was used for determination of the CAT activity as described previously. 33 The amounts of proteins and incubation times were 50 g and 180 min.
Production of amphotropic recombinant retrovirus
We constructed the two kinds of retroviral vectors in which the HSVtk gene expression was regulated by hybrid genes consisting of the wild-type or the varianttype of the 0.3 kb human AFP promoter, LNAFW0.3TK and LNAFM0.3TK, respectively. 5 The LTR constitutively regulates the neo gene expression, while the synthesis of the HSVtk protein largely depends on the wild-type or the variant-type of the AFP promoter-mediated transcription.
Amphotropic viruses were produced as described previously. 5 Briefly, the retroviral vectors, LNAFW0.3TK and LNAFM0.3TK, were transfected into Psi-2 ecotropic packaging cells using calcium phosphate precipitation. Two days later, each medium containing the ecotropic recombinant retrovirus was infected into PA317 amphotropic packaging cells. The virus-infected PA317 cells were selected in the medium containing 800 g/ml G418 (Gibco-BRL, Grand Island, NY, USA), and G418-resistant colonies were cloned using cloning cylinders.
Retroviral infection in hepatoma and nonhepatoma cell lines Amphotropic recombinant retroviruses, LNAFW0.3TK and LNAFM0.3TK, were harvested from the established producer cells, PA317/LNAFW0.3TK and PA317/ LNAFM0.3TK, respectively. The human hepatoma and nonhepatoma cells (1 × 10 6 ) were incubated for 4 h in 3 ml of virus supernatant plus 4 ml of the fresh medium containing 8 g/ml of polybrene. The cells were then cultured in complete medium containing G418 for 2 weeks. The concentrations of G418 used for each cell line were 600 g/ml for HuH-7, PLC/PRF/5 and huH-1/cl.2 and 400 g/ml for HeLa. G418-resistant pooled populations were subjected to further studies.
GCV-mediated cytotoxicity assays
The GCV-mediated cell growth inhibition was determined by the colorimetric method. The cells (1 × 10 4 per well) were placed on 48-well multiplates. One day later (day 0), the cells were incubated in 500 l of fresh media in the absence or presence of varying concentrations of GCV (Syntex, Palo Alto, CA, USA). Each medium was replaced with a corresponding fresh medium on days 2 and 4. To quantify the cell viability, 50 l of 5 mg/ml MTT (Sigma, St Louis, MO, USA) in PBS were added to each well. Cells were further cultured for 2 h at 37°C. The supernatants were aspirated and 100 l of n-propyl alcohol containing 0.1% NP40 and 4 × 10 where A is absorbance from the cells incubated with medium alone and B is absorbance from the cells incubated with the medium containing varying concentrations of GCV.
Analysis of bystander effect in virus-infected HuH-7 cells
The virus-infected HuH-7 cells and the parental cells were placed on the same well with different ratios at the cell density of 1 × 10 4 per well in 48-well multiplates. The cells were incubated at 37°C in 5% CO 2 in the absence or presence of 10 m GCV. Four days later, numbers of viable cells were quantified using the colorimetric method.
Statistical analysis
The statistical analyses were performed using the Student's t test. All P value were two-tailed and those less than 0.05 were considered statistically significant.
